Hepatocyte inflammation model for cytotoxicity research: Fructose or glycolaldehyde as a source of endogenous toxins

Archives of Physiology and Biochemistry

Volumn 115, Issue 2, 2009, Pages 105-111

  Feng, C Y ^b   Wong, S ^b   Dong, Q ^b,c   Bruce, J ^b   Mehta, R ^b   Bruce, W R ^b   O'Brien, P J ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NORTHWEST A F UNIVERSITY   (China)

Author keywords

Fructose; Glycolaldehyde; Glyoxal; Hepatocytes; Inflammation; Non alcoholic steatohepatitis; Reactive oxygen species

Indexed keywords

RATTUS;

ACETALDEHYDE; ANTIOXIDANT; DRUG DERIVATIVE; FRUCTOSE; GLYCOLALDEHYDE; GLYOXAL; HYDROGEN PEROXIDE; TOXIN;

ANIMAL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; INFLAMMATION; LIVER CELL; MALE; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RAT; RESEARCH; SPRAGUE DAWLEY RAT; TIME;

ACETALDEHYDE; ANIMALS; ANTIOXIDANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FRUCTOSE; GLYOXAL; HEPATOCYTES; HYDROGEN PEROXIDE; INFLAMMATION; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, SPRAGUE-DAWLEY; RESEARCH; TIME FACTORS; TOXINS, BIOLOGICAL;

EID: 68149108276     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.1080/13813450902887055     Document Type: Article

References (32)

1. Al-Maghrebi MA, Al-Mulla F, Benov LT. 2003. Glycolaldehyde induces apoptosis in a human breast cancer cell line. Arch Biochem Biophys 417(1):123-127
2. Buchweitz JP, Ganey PE, Bursian SJ, Roth RA. 2002. Underlying endotoxemia augments toxic responses to chlorpromazine: Is there a relationship to drug idiosyncrasy? J Pharmacol Exp Ther 300(2):460-467
3. Buriova E, Medova M, Macasek F, Bruder P. 2004. Separation and detection of oxidation products of fluorodeoxyglucose and glucose by high-performance liquid chromatographyelectrospray ionisation mass spectrometry. J Chromatogr A 1034(1/2):133-137
4. Butkovskaya NI, Pouvesle N, Kukui A, Bras GL. 2006. Mechanism of the OH-initiated oxidation of glycolaldehyde over the temperature range 233-296 K. J Phys Chem A 110(50):13492-13499 (Pubitemid 46196885)
5. Chan K, Jensen NS, Siber PM, O'Brien PJ. 2007. Structure- activity relationships for halobenzene induced cytotoxicity in rat and human hepatocytes. Chem Biol Interact 165(3):165-174
6. Chetyrkin SV, Mathis ME, Ham AJ, Hachey DL, Hudson BG, Voziyan PA. 2008. Propagation of protein glycation damage involves modification of tryptophan residues via reactive oxygen species: Inhibition by pyridoxamine. Free Radic Biol Med 44(7):1276-1285
7. Day CP, James OF. 1998. Steatohepatitis: A tale of two "hits"? Gastroenterology 114(4):842-845
8. de Alwis NM, Day CP. 2008. Non-alcoholic fatty liver disease: The mist gradually clears. J Hepatol 48 Suppl 1S104-S112.
9. Deng X, Stachlewitz RF, Liguori MJ, Blomme EA, Waring JF, Luyendyk JP, Maddox JF, Ganey PE, Roth RA. 2006. Modest inflammation enhances diclofenac hepatotoxicity in rats: Role of neutrophils and bacterial translocation. J Pharmacol Exp Ther 319(3):1191-1199
10. Glomb MA, Monnier VM. 1995. Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem 270(17):10017-10026
11. Hartley DP, Kroll DJ, Petersen DR. 1997. Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: Detection of 4-hydroxynonenal- and malondialdehyde-protein adducts. Chem Res Toxicol 10(8):895-905.
12. Hunt JV, Dean RT, Wolff SP. 1988. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J 256(1):205-212
13. Hyogo H, Yamagishi S, Iwamoto K, Arihiro K, Takeuchi M, Sato T, Ochi H, Nonaka M, Nabeshima Y, Inoue M, et al.. 2007. Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis. J Gastroenterol Hepatol 22(7):1112-1119
14. Kelley GL, Allan G, Azhar S. 2004. High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinology 145(2):548-555
15. Lawrence GD, Mavi A, Meral K. 2008. Promotion by phosphate of Fe(III)- and Cu(II)-catalyzed autoxidation of fructose. Carbohydr Res 343(4):626-635
16. Lee O, Bruce WR, Dong Q, Bruce J, Mehta R, O'Brien PJ. 2009. Fructose and carbonyl metabolites as endogenous toxins. Chem Biol Interact 178(1-3):332-339
17. Lu Y, Cederbaum AI. 2008. CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med 44(5):723-738
18. Maksimovic V, Mojovic M, Vucinic Z. 2006. Monosaccharide- H2O2 reactions as a source of glycolate and their stimulation by hydroxyl radicals. Carbohydr Res 341(14):2360-2369
19. Manini P, La PP, Panzella L, Napolitano A, d'Ischia M. 2006. Glyoxal formation by Fenton-induced degradation of carbohydrates and related compounds. Carbohydr Res 341(11):1828-1833
20. Moldeus P, Hogberg J, Orrenius S. 1978. Isolation and use of liver cells. Methods Enzymol 5260-5271
21. Morgan MJ, Kim YS, Liu ZG. 2008. TNFalpha and reactive oxygen species in necrotic cell death. Cell Res 18(3):343-349
22. Okado-Matsumoto A, Fridovich I. 2000. The role of alpha, betadicarbonyl compounds in the toxicity of short chain sugars. J Biol Chem 275(45):34853-34857
23. Ou P, Wolff SP. 1996. A discontinuous method for catalase determination at "near physiological" concentrations of H2O2 and its application to the study of H2O2 fluxes within cells. J Biochem Biophys Methods 31(1-2):59-67.
24. Shangari N, Chan TS, Popovic M, O'Brien PJ. 2006. Glyoxal markedly compromises hepatocyte resistance to hydrogen peroxide. Biochem Pharmacol 71(11):1610-1618
25. Stanhope KL, Griffen SC, Bair BR, Swarbrick MM, Keim NL, Havel PJ. 2008. Twenty-four-hour endocrine and metabolic profiles following consumption of high-fructose corn syrup-, sucrose-, fructose-, and glucose-sweetened beverages with meals. Am J Clin Nutr 87(5):1194-1203
26. Tafazoli S, Mashregi M, O'Brien PJ. 2008. Role of hydrazine in isoniazid-induced hepatotoxicity in a hepatocyte inflammation model. Toxicol Appl Pharmacol 229(1):94-101.
27. Tafazoli S, O'Brien PJ. 2008a. Accelerated cytotoxic mechanism screening of hydralazine using an in vitro hepatocyte inflammatory cell peroxidase model. Chem Res Toxicol 21(4):904-910
28. Tafazoli S, O'Brien PJ. 2008b. Amodiaquine-induced oxidative stress in a hepatocyte inflammation model. Toxicology
29. Takagi Y, Kashiwagi A, Tanaka Y, Asahina T, Kikkawa R, Shigeta Y. 1995. Significance of fructose-induced protein oxidation and formation of advanced glycation end product. J Diabetes Complications 9(2):87-91.
30. Thornalley PJ. 2003. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch Biochem Biophys 419(1):31-40.
31. Thornalley PJ, Langborg A, Minhas HS. 1999. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 344 Pt 1109-1116
32. Zeng J, Davies MJ. 2005. Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of alpha-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins. Chem Res Toxicol 18(8):1232-1241